Thursday, July 10, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Health

Rubicon develops global network with Canadian acquisition

Fiinews by Fiinews
January 10, 2020
in Health, Industry Sectors, Investment, Manufacturing, Projects
Reading Time: 2 mins read
A A
0
India INX
0
SHARES
10
VIEWS
LinkedinShare on Twitter

0:00

Rubicon-Impopharma plan new projects

 

Rubicon Research

As part of its ongoing effort to establish a global development network, Rubicon Research Private Limited is planning new projects with new acquisition Impopharma Canada Limited.

Over the next several months, the Company plans to establish development plans for a mix of both internal and external development projects, said Rubicon on 7 Jan 2020.

“I welcome the Impopharma team to the Rubicon Research family and look forward to building new projects and capabilities together,” said Parag Sancheti, Rubicon’s Chief Executive Officer.

Impopharma offers comprehensive drug product formulation and process development, as well as wide-ranging analytical testing services to the pharmaceutical industry, specializing in nasal and pulmonary drug products.

The 13,000 sq. ft. Impopharma site in Concord, near Toronto, has been previously inspected by the U.S. FDA and Health Canada and will be the nasal and pulmonary development Center of Excellence in the Rubicon network.

Impopharma Canada has been merged with Rubicon Research Canada Limited, a wholly owned subsidiary of Rubicon Research Private Limited.

Rubicon is a responsible partner to global healthcare innovators that design and deliver quality products for making patients’ lives healthy and happy. Rubicon also develops and commercializes its own value-added formulations in the global market.

Rubicon currently has several commercial products in the global market and a pipeline of over 60 products in development or under review.

Rubicon holds more than 50 issued patents in drug delivery technologies and with its new R&D center can develop pharmaceutical products across dosage forms.

The manufacturing facility located in Ambernath (India) has global regulatory approvals for commercial supply of oral solid dosage forms.

Rubicon also has a marketing office based in New Jersey. fiinews.com

ShareTweetShare

Related Posts

Delivery Of Nistar To Indian Navy
Projects

Project: Nistar delivered to Indian navy

by Fiinews
July 10, 2025
0
15

Keel laid for FSS at L&T Shipyard ‘Nistar’, the first indigenously designed and constructed Diving Support Vessel installed with state-of-the-art...

IVCA
Investment

Invest: India requires $150-$200bn for renewables

by Fiinews
July 10, 2025
0
25

Mumbai to host Renewable Energy Summit 2025 India will require another US$150-US$200 billion investments for renewables over the next five...

Tredence Logo

Tech: Tredence launches Agentic AI Playbook

July 10, 2025
13
PIB

Project: Trials of 17 ERASRs successful

July 10, 2025
15
PIB

Project: BEL works on NMDA for maritime security

July 10, 2025
14
Veeda Lifesciences Logo

Invest: Veeda to leverage Mango AI capabilities

July 9, 2025
12
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Tech: ansrsource-ANSR to reshape talent across India
  • Tech: Infogain launches GCC solutions in India
  • Market: Sai Parenterals goes global
  • Export: Rs.20lcr potential for Indian agriculture supplies
  • Project: Nistar delivered to Indian navy

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.